Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.39 |
| ▸ | OXER1 | Q8TDS5 | 7/20 | 0.36 |
| ▸ | REN | P00797 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | SPR | P35270 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25772253 | 0.85 | RORC (0.40) | OXER1S1PR1S1PR5 | |
| SCHEMBL25781205 | 0.85 | CYP4F2 (0.39) | CYP4F2CYP4A11S1PR1S1PR5NOTUM | |
| SCHEMBL25781207 | 0.82 | CYP4F2 (0.37) | CYP4F2CYP4A11S1PR1S1PR5NOTUM | |
| SCHEMBL25772194 | 0.82 | RORC (0.38) | CYP4F2CYP4A11S1PR1S1PR5 | |
| SCHEMBL25772307 | 0.81 | CYP4F2 (0.37) | CYP4F2CYP4A11S1PR1S1PR5SPR | |
| SCHEMBL25780884 | 0.81 | OXER1 (0.51) | OXER1 | |
| SCHEMBL25780952 | 0.81 | OXER1 (0.51) | OXER1 | |
| SCHEMBL25783158 | 0.80 | S1PR1 (0.40) | CYP4F2CYP4A11RENS1PR1S1PR5 | |
| SCHEMBL25782854 | 0.79 | S1PR1 (0.40) | CYP4F2CYP4A11S1PR1S1PR5NOTUM | |
| SCHEMBL25783157 | 0.78 | S1PR1 (0.39) | CYP4F2CYP4A11S1PR1S1PR5SPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115203-A1 | OXER1 ANTAGONISTS AND USES THEREOF | FAIRHAVEN PHARMACEUTICALS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |